Anele Gela is a Research Officer at the University of Cape Town. He received his M.Sc in Molecular Virology from the University of the Western Cape in 2011, completed a Ph.D. degree in 2016 at Lund University in the field of respiratory medicine and allergology, and later transitioned to TB vaccines and clinical immunology at the South African Tuberculosis Vaccine Initiative, University of Cape Town. During his post-doctoral training, he was actively involved in several projects which aimed to address the role of donor-unrestricted T (DURT) cells in mycobacterial immunity and vaccination. His research focus is on identifying host determinant of protective immunity against Mycobacterium tuberculosis.
Anele Gela is a Research Officer at the University of Cape Town. He received his M.Sc in Molecular Virology from the University of the Western Cape in 2011, completed a Ph.D. degree in 2016 at Lund University in the field of respiratory medicine and allergology, and later transitioned to TB vaccines and clinical immunology at the South African Tuberculosis Vaccine Initiative, University of Cape Town. During his post-doctoral training, he was actively involved in several projects which aimed to address the role of donor-unrestricted T (DURT) cells in mycobacterial immunity and vaccination. His research focus is on identifying host determinant of protective immunity against Mycobacterium tuberculosis.